{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-256699","form_type":"8-K","ticker":"ORGO","cik":"0001661181","company_name":"Organogenesis Holdings Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.142989+00:00","generated_at":"2026-05-30T00:57:28.536020+00:00","sec_items":["1.01","5.03","2.04","3.02","3.03","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Organogenesis raises $130M convertible preferred, repurchases 7.4M shares, appoints Avista director","bullets":["Sold 130,000 shares of Series A Convertible Preferred Stock at $1,000/share for gross proceeds of $130M.","Net proceeds used for strategic growth, debt repayment, and repurchase of 7.4M common shares from directors at $3.1597/share (~$23.5M).","Preferred pays 8% annual dividend, compounded quarterly, payable in cash or PIK; conversion price initially $3.7917 (20% premium).","Company expects to prepay ~$62.5M term loan principal and interest on Nov 13, 2024, using offering proceeds.","Appointed Garrett Lustig (Avista Principal) to Board, increasing board size to twelve."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-256699","json":"https://secwatch.observer/filing/0001193125-24-256699.json","markdown":"https://secwatch.observer/filing/0001193125-24-256699.md","text":"https://secwatch.observer/filing/0001193125-24-256699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661181/000119312524256699/0001193125-24-256699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661181/000119312524256699/d885519d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:57:28.536020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8e553b1936","claim":"Garrett Lustig was appointed as Director at Organogenesis Holdings Inc..","evidence_excerpt":"On November 12, 2024, the Board appointed Garrett Lustig to the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312524256699/0001193125-24-256699-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}